Budesonide Suspension
Product Images NDC 59651-585

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Budesonide (NDC 59651-585). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-1 (Budesonide Fig1)

Figure-1 (Budesonide Fig1)
FDA Label Image

Figure-2 (Budesonide Fig2)

Figure-2 (Budesonide Fig2)
FDA Label Image

Figure-3 (Budesonide Fig3)

Figure-3 (Budesonide Fig3)
FDA Label Image

Figure-4 (Budesonide Fig4)

Figure-4 (Budesonide Fig4)
FDA Label Image

Figure-5 (Budesonide Fig5)

Figure-5 (Budesonide Fig5)
FDA Label Image

Figure-6 (Budesonide Fig6)

Figure-6 (Budesonide Fig6)
FDA Label Image

Figure-7 (Budesonide Fig7)

Figure-7 (Budesonide Fig7)
FDA Label Image

Package Label.principal Display Panel-0.5 mg Per 2ml (Printed Triple Laminated Pouch Label)

Package Label.principal Display Panel-0.5 mg Per 2ml (Printed Triple Laminated Pouch Label)
Not available.*
FDA Label Image

Package Label.principal Display Panel-0.5 mg Per 2ml (Carton)

Package Label.principal Display Panel-0.5 mg Per 2ml (Carton)
FDA Label Image

Budesonide-structure (Budesonide Str)

Budesonide-structure (Budesonide Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.